Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients

BACKGROUND: There is no agreed upon standard of care for borderline‐resectable pancreatic cancer (BRPC) or locally‐advanced pancreatic cancer (LAPC) patients regarding the benefit of chemotherapy or radiation alone or in combination. PATIENTS AND METHODS: We completed a retrospective cohort analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Botta, Gregory P., Huynh, Tridu R., Spierling‐Bagsic, Samantha R., Agelidis, Alexander, Schaffer, Randolph, Lin, Ray, Sigal, Darren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134275/
https://www.ncbi.nlm.nih.gov/pubmed/36478411
http://dx.doi.org/10.1002/cam4.5523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134275/
https://www.ncbi.nlm.nih.gov/pubmed/36478411
http://dx.doi.org/10.1002/cam4.5523

Ejemplares similares